Julio Granados Selected Research

Enzymes

8/2020	Antioxidant Enzymes Haplotypes and Polymorphisms Associated with Obesity in Mexican Children.
4/2014	Clinical, histological and molecular characteristics of Mexican patients with Fabry disease and significant renal involvement.
12/2006	Role of the HLA-DQ locus in the development of chronic gastritis and gastric carcinoma in Mexican patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Granados Research Topics

Disease

16	Genetic Predisposition to Disease (Genetic Predisposition) 08/2021 - 01/2003
11	Infections 10/2023 - 11/2002
10	Obesity 10/2023 - 07/2010
6	Tuberculosis (Tuberculoses) 06/2020 - 12/2005
5	Neoplasms (Cancer) 01/2021 - 05/2011
5	Rheumatoid Arthritis 01/2020 - 02/2004
4	COVID-19 10/2023 - 01/2021
3	Inflammation (Inflammations) 10/2023 - 06/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2019
3	Rheumatic Diseases (Rheumatism) 06/2020 - 05/2011
3	Ulcerative Colitis 01/2020 - 08/2004
3	Leprosy (Hansen's Disease) 01/2017 - 11/2013
3	Papillomavirus Infections 08/2013 - 10/2004
2	Virus Diseases (Viral Diseases) 10/2023 - 06/2014
2	Takayasu Arteritis (Arteritis, Takayasu's) 03/2023 - 01/2005
2	Critical Illness (Critically Ill) 01/2022 - 10/2015
2	Human Influenza (Influenza) 01/2021 - 10/2015
2	Neuromyelitis Optica (Devic's Disease) 01/2021 - 01/2018
2	Vitiligo 01/2021 - 01/2005
2	Overweight 08/2020 - 11/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018 - 02/2007
2	Onychomycosis (Tinea Unguium) 09/2016 - 12/2010
2	Systemic Scleroderma (Systemic Sclerosis) 07/2016 - 01/2015
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2014 - 04/2008
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2013 - 07/2007
2	Hypertension (High Blood Pressure) 01/2013 - 02/2005
2	Dengue (Dengue Fever) 10/2011 - 11/2002
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2011 - 01/2009
2	Type 2 Diabetes Mellitus (MODY) 07/2010 - 02/2007
2	Autoimmune Hepatitis 01/2009 - 03/2007
2	Pemphigus (Pemphigus Vulgaris) 09/2007 - 04/2005
2	Gastritis 12/2006 - 05/2004
2	Reactive Arthritis (Reiter Disease) 10/2006 - 12/2004
2	Ankylosing Spondylitis 10/2006 - 12/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2023
1	Insulin Resistance 01/2023
1	Melanoma (Melanoma, Malignant) 09/2022
1	Dyslipidemias (Dyslipidemia) 12/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2021
1	Gastroesophageal Reflux (GERD) 05/2021
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2021
1	Atherosclerotic Plaque (Atheroma) 12/2020
1	Acute Coronary Syndrome 12/2020

Drug/Important Bio-Agent (IBA)

15	HLA-DRB1 Chains (HLA DRB1)IBA 09/2022 - 01/2003
12	HLA Antigens (Human Leukocyte Antigens)IBA 03/2023 - 07/2002
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 08/2003
10	HLA-DR Antigens (HLA-DR)IBA 09/2016 - 03/2002
9	AntigensIBA 12/2018 - 03/2002
7	CytokinesIBA 05/2021 - 02/2005
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2004
5	HLA-DQB1 antigen (HLA DQB1)IBA 09/2022 - 05/2004
4	CholesterolIBA 12/2021 - 07/2010
4	Genetic Markers (Genetic Marker)IBA 11/2019 - 01/2009
4	AutoantibodiesIBA 12/2018 - 01/2009
3	EnzymesIBA 08/2020 - 12/2006
3	HLA-A Antigens (HLA-A)IBA 01/2018 - 11/2009
3	AntibodiesIBA 02/2016 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2002
3	HLA-B Antigens (HLA-B)IBA 01/2013 - 01/2005
3	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 10/2004 - 07/2002
2	AcidsIBA 10/2023 - 01/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2023 - 09/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2023 - 01/2023
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2019
2	Insulin (Novolin)FDA Link 01/2023 - 12/2018
2	HLA-DQA1 antigen (HLA DQA1)IBA 09/2022 - 05/2004
2	LipidsIBA 12/2021 - 10/2009
2	Apolipoproteins B (ApoB)IBA 12/2021 - 05/2017
2	Histocompatibility Antigens Class IIIBA 01/2021 - 08/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 10/2015
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021 - 10/2015
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2015
2	HLA-DRB1*04 antigenIBA 01/2021 - 01/2014
2	ChemokinesIBA 12/2020 - 10/2015
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	Type 1 Angiotensin ReceptorIBA 07/2016 - 01/2013
2	Tuberculin (PPD)IBA 02/2016 - 02/2010
2	HLA-DR7 Antigen (HLA DR7 Antigen)IBA 01/2011 - 07/2002
2	Apolipoproteins E (ApoE)IBA 10/2010 - 10/2009
2	ApolipoproteinsIBA 10/2009 - 09/2002
2	HLA-DQbeta antigenIBA 02/2007 - 05/2004
2	HLA-DQ Antigens (HLA-DQ)IBA 12/2006 - 05/2004
1	fibrin fragment D (D-dimer)IBA 10/2023
1	Myeloid Differentiation Factor 88IBA 10/2023
1	HDL LipoproteinsIBA 01/2023
1	Arachidonic Acid (Vitamin F)IBA 01/2023
1	Docosahexaenoic AcidsIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	HLA-A*68 antigenIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	oxidized low density lipoproteinIBA 12/2021
1	Inflammation MediatorsIBA 05/2021
1	Thymopoietins (TP 49)IBA 01/2021
1	Ifosfamide FDA LinkGeneric 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021

Therapy/Procedure

5	Therapeutics 06/2020 - 11/2013